|
Secondary prevention
Citations 201-210 of 566 total displayed.
|
Past content
(since Feb 1999):
|
- Cardiology Patient Pages
Learn, Take Action, and Live: A Guide to Using Online Tools to Prevent and Manage Heart Disease and Stroke
- Suzanna Phelps-Fredette
Circulation 2005;112:e318-319e, doi:10.1161/CIRCULATIONAHA.105.590794
[Full text]
- Coronary Heart Disease
Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
- Chris J. Packard, Ian Ford, Michele Robertson, James Shepherd, Gerard J. Blauw, Michael B. Murphy, Edward L.E.M. Bollen, Brendan M. Buckley, Stuart M. Cobbe, Allan Gaw, Michael Hyland, J. Wouter Jukema, Adriaan M. Kamper, Peter W. Macfarlane, Ivan J. Perry, David J. Stott, Brian J. Sweeney, Cillian Twomey, Rudi G.J. Westendorp for the PROSPER Study Group
Circulation 2005;112:3058-3065; published online before print as doi:10.1161/CIRCULATIONAHA.104.526848
[Abstract]
[Full text]
- AHA Scientific Statements
Managing Abnormal Blood Lipids: A Collaborative Approach
- Barbara Fletcher, Kathy Berra, Phil Ades, Lynne T. Braun, Lora E. Burke, J. Larry Durstine, Joan M. Fair, Gerald F. Fletcher, David Goff, Laura L. Hayman, William R. Hiatt, Nancy Houston Miller, Ronald Krauss, Penny Kris-Etherton, Neil Stone, Janet Wilterdink, and Mary Winston
Circulation 2005;112:3184-3209, doi:10.1161/CIRCULATIONAHA.105.169180
[Abstract]
[Full text]
- Articles
Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
- Chris J. Packard, Ian Ford, Michele Robertson, James Shepherd, Gerard J. Blauw, Michael B. Murphy, Edward L.E.M. Bollen, Brendan M. Buckley, Stuart M. Cobbe, Allan Gaw, Michael Hyland, J. Wouter Jukema, Adriaan M. Kamper, Peter W. Macfarlane, Ivan J. Perry, David J. Stott, Brian J. Sweeney, Cillian Twomey, Rudi G.J. Westendorp for the PROSPER Study Group
Circulation published November 7, 2005, doi:10.1161/CIRCULATIONAHA.104.526848
[Abstract]
- Arrhythmia/Electrophysiology
Prevention of Fatal Arrhythmias in High-Risk Subjects by Fish Oil n-3 Fatty Acid Intake
- Alexander Leaf, Christine M. Albert, Mark Josephson, David Steinhaus, Jeffrey Kluger, Jing X. Kang, Benjamin Cox, Hui Zhang, David Schoenfeld for the Fatty Acid Antiarrhythmia Trial Investigators
Circulation 2005;112:2762-2768, doi:10.1161/CIRCULATIONAHA.105.549527
[Abstract]
[Full text]
- Cardiology Patient Pages
Heart Attack and Stroke Prevention in Women
- Richard C. Becker
Circulation 2005;112:e273-275e, doi:10.1161/CIRCULATIONAHA.105.551341
[Full text]
- Correspondence
Letters Regarding Article by Patti et al, "Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study" • Response
- Pierluigi Tricoci, Robert A. Harrington, Marco Valgimigli, Theresa M. Palabrica, Paul B. Burton, Giuseppe Patti, Leonardo Lassandro Pepe, Germano Di Sciascio, Giuseppe Colonna, Antonio Montinaro, and Vincenzo Pasceri
Circulation 2005;112:e282-283e, doi:10.1161/CIRCULATIONAHA.105.568139
[Full text]
- Surgery for Aortic and Peripheral Vascular Disease
Large Area of the False Lumen Favors Secondary Dilatation of the Aorta After Acute Type A Aortic Dissection
- Franz F. Immer, Eva Krähenbühl, Urs Hagen, Mario Stalder, Pascal A. Berdat, Friedrich S. Eckstein, Jürg Schmidli, and Thierry P. Carrel
Circulation 2005;112:I-249-252I-, doi:10.1161/CIRCULATIONAHA.104.525733
[Abstract]
[Full text]
- Health Services and Outcomes Research
Impact of the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22/Reversal of Atherosclerosis With Aggressive Lipid Lowering Trials on Trends in Intensive Versus Moderate Statin Therapy in Ontario, Canada
- Peter C. Austin and Muhammad M. Mamdani
Circulation 2005;112:1296-1300; published online before print as doi:10.1161/CIRCULATIONAHA.104.531582
[Abstract]
[Full text]
- Preventive Cardiology
Long-Term Effects of Ramipril on Cardiovascular Events and on Diabetes: Results of the HOPE Study Extension
- HOPE/HOPE-TOO Study Investigators
Circulation 2005;112:1339-1346, doi:10.1161/CIRCULATIONAHA.105.548461
[Abstract]
[Full text]
|
|
